CLOV — Clover Health Investments Income Statement
0.000.00%
Last trade - 00:00
- $314.81m
- $16.49m
- $2.03bn
- 30
- 62
- 53
- 47
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS/A | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 1,472 | 3,477 | 2,034 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.018 | 6.86 | 2,109 | 3,824 | 2,242 |
Operating Profit | -0.018 | -6.86 | -637 | -348 | -209 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.018 | -6.74 | -588 | -339 | -213 |
Net Income After Taxes | -0.018 | -6.74 | -588 | -339 | -213 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.018 | -6.74 | -588 | -339 | -213 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.018 | -6.74 | -588 | -339 | -213 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0 | -0.065 | -1.42 | -0.76 | -0.389 |
Dividends per Share |